Can a lipid cream stop healed wounds from reopening?

NCT ID NCT02577120

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 38 times

Summary

This study tests whether a special lipid cream (EpiCeram) can prevent healed chronic wounds—like diabetic foot ulcers or pressure sores—from reopening. About 100 adults with recently healed wounds will apply either the cream or Vaseline for 3 months. Researchers will measure skin barrier function to see if the cream helps wounds stay closed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURN WOUND are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Pittsburgh / McKeesport Clinic

    Pittsburgh, Pennsylvania, 15132, United States

  • University of Pittsburgh / Mercy Clinic

    Pittsburgh, Pennsylvania, 15219, United States

  • University of Pittsburgh / Passavant

    Pittsburgh, Pennsylvania, 16066, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

EpiCeram (lipid-rich cream) and Vaseline (petroleum jelly)

What this could lead to

If successful, this could point toward a simple cream to reduce the chance that a healed chronic wound reopens.

What could go wrong

This is an early-phase study with a small number of participants, so results may not apply broadly. The cream is compared to Vaseline, and the main measure (TEWL) is a skin function test, not a direct clinical outcome.

Conditions

The condition(s) this trial relates to.

Bronchiolitis Obliterans Syndrome burn chronic ulcer of skin decubitus ulcer Diabetic Foot injury ulcer of lower limbs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.